Search

Your search keyword '"Schätzlein AG"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Schätzlein AG" Remove constraint Author: "Schätzlein AG"
58 results on '"Schätzlein AG"'

Search Results

1. Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis

2. Delivering cancer stem cell therapies - a role for nanomedicines?

4. The influence of amphiphilic quaternary ammonium palmitoyl glycol chitosan (GCPQ) polymer composition on oil-loaded nanocapsule architecture.

5. Targeting Intracranial Tumours with a Combination of RNA and Chemotherapy.

6. Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents-A Novel Polymer Formulation for Anticancer Therapy.

7. High-capacity glycol chitosan-based nanoemulsion for efficient delivery of disulfiram.

8. Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform.

9. Brain Gene Silencing with Cationic Amino-Capped Poly(ethylene glycol) Polyplexes.

10. The topical ocular delivery of rapamycin to posterior eye tissues and the suppression of retinal inflammatory disease.

11. Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes.

12. Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure.

13. SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray.

14. Development of Bio-Functionalized, Raman Responsive, and Potentially Excretable Gold Nanoclusters.

15. Polymeric Micelles for the Enhanced Deposition of Hydrophobic Drugs into Ocular Tissues, without Plasma Exposure.

16. Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.

17. Achieving highly efficient gene transfer to the bladder by increasing the molecular weight of polymer-based nanoparticles.

18. Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route.

19. A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production.

20. Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC ® Natural Adjuvant against Aspergillosis.

21. Nose-to-Brain Delivery.

22. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.

23. Nanomedicines in the treatment of brain tumors.

24. Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia.

25. Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors.

26. Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments.

27. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.

28. Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.

29. Physical characterisation and long-term stability studies on quaternary ammonium palmitoyl glycol chitosan (GCPQ)--a new drug delivery polymer.

30. Optimisation of synthetic vector systems for cancer gene therapy - the role of the excess of cationic dendrimer under physiological conditions.

31. Dextran-pegylated microparticles for enhanced cellular uptake of hydrophobic drugs.

32. Nanofiber-based delivery of therapeutic peptides to the brain.

33. Amphiphilic poly(L-amino acids) - new materials for drug delivery.

34. A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain.

35. Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.

36. Polyamine aza-cyclic compounds demonstrate anti-proliferative activity in vitro but fail to control tumour growth in vivo.

37. Cancer and the blood-brain barrier: 'Trojan horses' for courses?

38. High-resolution 3D isotropic MR imaging of mouse flank tumours obtained in vivo with solenoid RF micro-coil.

39. A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.

40. Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds.

41. Dendrimers in gene delivery.

42. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.

43. Tumour gene expression from C12 spermine amphiphile gene delivery systems.

44. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain.

45. Tumour-targeted drug and gene delivery: principles and concepts.

46. PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility.

47. Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles.

48. Gene transfer with three amphiphilic glycol chitosans--the degree of polymerisation is the main controller of transfection efficiency.

49. In vitro and in vivo gene transfer with poly(amino acid) vesicles.

50. Quantification of beta-galactosidase activity after non-viral transfection in vivo.

Catalog

Books, media, physical & digital resources